Sarcoma

Research conducted by: RAND Health

All Items (316)

Journal Article

Landmark Risk Prediction of Residual Life for Breast Cancer Survival — Jan 1, 2013

The importance of developing personalized risk prediction estimates has become increasingly evident in recent years.

Journal Article

What Is the Price of Prevention? New Evidence from a Field Experiment — Jan 1, 2013

Policies to increase preventive testing in developing countries should include subsidies towards treatment costs.

Blog

Understanding the Roots of Dramatic Black-White Cancer Disparities in the Nation'™s Capital — Oct 22, 2012

cancer cells

The burden of cancer is not experienced equally across the population: Nationwide, black Americans have higher rates of death from cancer than white Americans, and nowhere has this disparity been more apparent than in the nation's capital, writes Rebecca Anhang Price.

News Release

Cancer Disparities Between D.C. Blacks and Whites Greater Than Those Nationwide — Oct 22, 2012

Across the United States in 2009, overall cancer incidence was 4 percent higher among blacks than among whites. The disparity was more striking in Washington, D.C., where the overall cancer incidence among black residents was 54 percent higher than the incidence among white residents.

Report

Cancer Disparities Between D.C. Blacks and Whites Greater Than Those Nationwide — Oct 22, 2012

Across the United States in 2009, overall cancer incidence was 4 percent higher among blacks than among whites. The disparity was more striking in Washington, D.C., where the overall cancer incidence among black residents was 54 percent higher than the incidence among white residents.

Project

Evaluating the University College Hospital Macmillan Cancer Centre Programme — Aug 10, 2012

Because cancer patients often receive poorly organised and fragmented care, University College Hospital Trust and Macmillan Cancer Support have established a new cancer centre. RAND Europe is evaluating the centre's efforts and developing a sustainable quality improvement environment across the partnership.

Journal Article

Effect of Adjuvant Chemotherapy on Survival of Patients with Stage III Colon Cancer Diagnosed After Age 75 Years — Jul 1, 2012

Few patients 75 years of age and older participate in clinical trials, thus whether adjuvant chemotherapy for stage III colon cancer (CC) benefits this group is unknown.

Journal Article

Introduction: Understanding and Influencing Multilevel Factors Across the Cancer Care Continuum — May 1, 2012

Health care in the United States is notoriously expensive while often failing to deliver the care recommended in published guidelines.

Journal Article

Computational Modeling and Multilevel Cancer Control Interventions — May 1, 2012

This chapter presents an overview of computational modeling as a tool for multilevel cancer care and intervention research.

Journal Article

Pediatric Cancer Hospitalizations, 2009 — May 1, 2012

This Statistical Brief presents data from the Healthcare Cost and Utilization Project (HCUP) on hospital stays for cancer care in individuals under 18 years of age in 2009.

Journal Article

Patients Value Metastatic Cancer Therapy More Highly Than Is Typically Shown Through Traditional Estimates — Apr 1, 2012

There is a growing emphasis on promoting medical treatments that provide the most benefits relative to their costs.

Journal Article

How Cancer Patients Value Hope and the Implications for Cost-Effectiveness Assessments of High-Cost Cancer Therapies — Apr 1, 2012

Assessments of the medical and economic value of therapies in diseases such as cancer traditionally focus on average or median gains in patients' survival.

Journal Article

An Analysis of Whether Higher Health Care Spending in the United States Versus Europe Is 'Worth It' in the Case of Cancer — Apr 1, 2012

The higher-cost US system of cancer care delivery may be worth it, although further research is required to determine what specific tools or treatments are driving improved cancer survival in the United States.

Journal Article

Comparative Effectiveness of Oxaliplatin Vs Non-Oxaliplatin-Containing Adjuvant Chemotherapy for Stage III Colon Cancer — Feb 1, 2012

The addition of oxaliplatin to 5-FU appears to be associated with better survival among patients receiving adjuvant colon cancer treatment in the community.

Journal Article

Cancer Hospitalizations for Adults, 2009 — Feb 1, 2012

Cancer is the leading cause of death among men and women under age 85.

Journal Article

Representativeness of Participants in the Cancer Care Outcomes Research and Surveillance Consortium Relative to the Surveillance, Epidemiology, and End Results Program — Jan 1, 2012

This study demonstrates that the CanCORS Consortium was successful in enrolling a demographically representative sample within the CanCORS regions.

Journal Article

Prevalence, Predictors, and Patient Outcomes Associated with Physician Co-Management: Findings from the Los Angeles Women's Health Study — Jan 1, 2012

Physician co-management, representing joint participation in the planning, decision-making, and delivery of care, is often cited in association with coordination of care. Yet little is known about how physicians manage tasks and how their management style impacts patient outcomes.

Journal Article

Anaplastic Large Cell Lymphoma and Breast Implants: Results from a Structured Expert Consultation Process — Sep 1, 2011

Experts agree on many key issues regarding anaplastic large cell lymphoma in women with breast implants, but substantial research is needed to improve our understanding of the epidemiology, clinical aspects, and biology of this disease.

Journal Article

Are United States and Canadian Cancer Screening Rates Consistent with Guideline Information Regarding the Age of Screening Initiation? — Sep 1, 2011

US and Canadian differences in cancer screening due to each country's guidelines can potentially explain cross-country differences in breast cancer mortality and affect interpretation of international comparisons of cancer statistics.

Journal Article

Use of Colony-Stimulating Factors with Chemotherapy: Opportunities for Cost Savings and Improved Outcomes — Jun 1, 2011

Decreased use of myeloid colony-stimulating factors in patients at lower or intermediate risk of febrile neutropenia from high-risk chemotherapy regimens could yield substantial cost savings without compromising patient outcomes.

My RAND ?

Saved Items

Recommended